Anthropometric measures and biochemical analyses showed that subjects with NW presented lower weight, BMI, HbA1c and TG than MO patients; furthermore, glucose, insulin, homeostatic model assessment method-insulin resistance (HOMA1-IR), AST and ALT were lower than in SS and NASH groups; also, gamma-glutamyltransferase (GGT) levels were reduced in comparison with NASH women. Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.